Journal of Molecular Neuroscience

, Volume 50, Issue 1, pp 98–108 | Cite as

Neuroprotective Effect of Protease-Activated Receptor-2 in the Hypoxia-Induced Apoptosis of Rat RGC-5 Cells

Article

Abstract

Hypoxia-induced apoptosis of retinal ganglion cells (RGCs) is regarded as a pivotal pathological process in various ocular diseases. Protease-activated receptor-2 (PAR-2) is involved in the regulation of cell inflammation, differentiation, and apoptosis in many cell types and tissues, but the role of PAR-2 in RGCs under pathological conditions remains unknown. The purpose of this study was to investigate the role of PAR-2 in the apoptosis of RGCs under hypoxic stress. An immortalized rat RGC line (RGC-5) was exposed to hypoxia (5 % O2). The expression and location of PAR-2 in RGC-5 cells under hypoxia stress were investigated using real-time PCR, western blotting and immunocytochemistry. Cell viability was determined using the Cell Counting Kit-8 assay. Apoptosis was detected using Hoechst 33342 staining and AnnexinV-FITC/PI assays. The role of Bcl-2, Bax, and the active subunit of caspase-3 was also investigated. The results showed that PAR-2 was functionally expressed in RGC-5 cells and up-regulated at both mRNA and protein levels under hypoxic stress. The PAR-2 selective agonist, SLIGRL, rescued RGC-5 cells from hypoxia-induced apoptosis through up-regulation of the Bcl-2/Bax ratio and down-regulation of caspase-3 activation. This study provides the first evidence that PAR-2 has a protective effect against the hypoxia-induced apoptosis of RGC-5 cells.

Keywords

Protease-activated receptor-2 RGC-5 cells Hypoxia Apoptosis Caspase-3 Bcl-2/Bax ratio 

References

  1. Adams MN, Ramachandran R, Yau MK et al (2011) Structure, function and pathophysiology of protease activated receptors. Pharmacol Ther 130:248–282PubMedCrossRefGoogle Scholar
  2. Amadesi S, Bunnett N (2004) Protease-activated receptors: protease signaling in the gastrointestinal tract. Curr Opin Pharmacol 4:551–556PubMedCrossRefGoogle Scholar
  3. Barnes JA, Singh S, Gomes AV (2004) Protease activated receptors in cardiovascular function and disease. Mol Cell Biochem 263:227–239PubMedCrossRefGoogle Scholar
  4. Borensztajn K, Bresser P, van der Loos C et al (2010) Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury. Am J Pathol 177:2753–2764PubMedCrossRefGoogle Scholar
  5. Bushell T (2007) The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disorders. J Physiol 581:7–16PubMedCrossRefGoogle Scholar
  6. Cocks T, Moffatt J (2001) Protease-activated receptor-2 (PAR2) in the airways. Pulm Pharmacol Ther 14:183–191PubMedCrossRefGoogle Scholar
  7. Dery O, Bunnett N (1999) Proteinase-activated receptors: a growing family of heptahelical receptors for thrombin, trypsin and tryptase. Biochem Soc Trans 27:246–254PubMedGoogle Scholar
  8. Frassetto LJ (2006) Kinase-dependent differentiation of a retinal ganglion cell precursor. Investig Ophthalmol Vis Sci 47:427–438CrossRefGoogle Scholar
  9. Goldenberg-Cohen N, Dadon S, Avraham B-CR et al (2008) Molecular and histological changes following central retinal artery occlusion in a mouse model. Exp Eye Res 87:327–333PubMedCrossRefGoogle Scholar
  10. Greenwood SM, Bushell TJ (2010) Astrocytic activation and an inhibition of MAP kinases are required for proteinase–activated receptor–2–mediated protection from neurotoxicity. J Neurochem 113:1471–1480PubMedGoogle Scholar
  11. Gupta S (2003) Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). Int J Oncol 22:15–20PubMedGoogle Scholar
  12. Herve Y, Sroussi YL, Villines D, Sun Y (2012) The down regulation of neutrophil oxidative metabolism by S100A8 and S100A9: implication of the protease-activated receptor-2. Mol Immunol 50:42–48CrossRefGoogle Scholar
  13. Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334–336PubMedCrossRefGoogle Scholar
  14. Hong S, Lee J, Kim C, Seong GJ (2007) Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line. BMC Neurosci 8:81–92PubMedCrossRefGoogle Scholar
  15. Jacobson MD, Evan GI (1994) Apoptosis: breaking the ICE. Curr Biol 4:337–340PubMedCrossRefGoogle Scholar
  16. Jesmin S, Gando S, Zaedi S, Sakuraya F (2006) Differential expression, time course and distribution of four PARs in rats with endotoxin-induced acute lung injury. Inflammation 30:14–27PubMedCrossRefGoogle Scholar
  17. Jin G, Hayashi T, Kawagoe J et al (2005) Deficiency of PAR-2 gene increases acute focal ischemic brain injury. J Cereb Blood Flow Metab 25:302–313PubMedCrossRefGoogle Scholar
  18. Kaur C, Foulds WS, Ling EA (2008) Hypoxia–ischemia and retinal ganglion cell damage. Clin Ophthalmol (Auckland, NZ) 2:879–889CrossRefGoogle Scholar
  19. Kaushik S, Pandav S, Ram J (2003) Neuroprotection in glaucoma. J Postgrad Med 49:90–95PubMedCrossRefGoogle Scholar
  20. Kawabata A (2002) PAR-2: structure, function and relevance to human diseases of the gastric mucosa. Expert Rev Mol Med 2:1–17CrossRefGoogle Scholar
  21. Kawabata A (2003) Gastrointestinal functions of proteinase-activated receptors. Life Sci 74:247–254PubMedCrossRefGoogle Scholar
  22. Kawabata A, Kuroda R (2000) Protease-activated receptor (PAR), a novel family of G protein-coupled seven trans-membrane domain receptors: activation mechanisms and physiological roles. Jpn J Pharmacol 82:171–174PubMedCrossRefGoogle Scholar
  23. Kelso EB (2005) Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation. J Pharmacol Exp Ther 316:1017–1024PubMedCrossRefGoogle Scholar
  24. Kergoat H, Herard ME, Lemay M (2006) RGC sensitivity to mild systemic hypoxia. Investig Ophthalmol Vis Sci 47:5423–5427CrossRefGoogle Scholar
  25. Krishnamoorthy R, Agarwal P, Prasanna G et al (2001) Characterization of a transformed rat retinal ganglion cell line. Mol Brain Res 86:1–12PubMedCrossRefGoogle Scholar
  26. Lakhani SA, Masud A, Kuida K et al (2006) Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Sci STKE 311:847–851Google Scholar
  27. Leger AJ, Covic L, Kuliopulos A (2006) Protease-activated receptors in cardiovascular diseases. Circulation 114:1070–1077PubMedCrossRefGoogle Scholar
  28. Li R, Reiser G (2011) Phosphorylation of Ser45 and Ser59 of αB-crystallin and p38/extracellular regulated kinase activity determine αB-crystallin-mediated protection of rat brain astrocytes from C2-ceramide- and staurosporine-induced cell death. J Neurochem 118:354–364PubMedCrossRefGoogle Scholar
  29. Li R, Rohatgi T, Hanck T, Reiser G (2009) αA-crystallin and αB-crystallin, newly identified interaction proteins of protease-activated receptor-2, rescue astrocytes from C2-ceramide- and staurosporine-induced cell death. J Neurochem 110:1433–1444PubMedCrossRefGoogle Scholar
  30. Linsenmeier RA, Braun RD, McRipley MA et al (1998) Retinal hypoxia in long-term diabetic cats. Investig Ophthalmol Vis Sci 39:1647–1657Google Scholar
  31. Luo W, Wang Y, Reiser G (2005) Two types of protease-activated receptors (PAR-1 and PAR-2) mediate calcium signaling in rat retinal ganglion cells RGC-5. Brain Res 1047:159–167PubMedCrossRefGoogle Scholar
  32. Luo W, Wang Y, Reiser G (2007a) Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection. Brain Res Rev 56:331–345PubMedCrossRefGoogle Scholar
  33. Luo W, Wang Y, Reiser G (2007b) Proteinase-activated receptor-1 and −2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain. Biochem J 401:65–78PubMedCrossRefGoogle Scholar
  34. Marzo I, Brenner C, Zamzami N et al (1998) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281:2027–2031PubMedCrossRefGoogle Scholar
  35. Menzel-Severing J, Siekmann U, Weinberger A, Roessler G, Walter P, Mazinani B (2012) Early hyperbaric oxygen treatment for nonarteritic central retinal artery obstruction. Am J Ophthalmol 454–459Google Scholar
  36. Napoli C, Cicala C, Wallace JL et al (2000) Protease-activated receptor-2 modulates myocardial ischemia–reperfusion injury in the rat heart. Proc Natl Acad Sci 97:3678–3683PubMedCrossRefGoogle Scholar
  37. Noorbakhsh F, Vergnolle N, McArthur JC et al (2005) Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection. J Immunol 174:7320–7329PubMedGoogle Scholar
  38. Oltval ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 74:609–619CrossRefGoogle Scholar
  39. Pournaras C, Illic J, Gilodi N (1985) Retinal vascular occlusion: possibilities of a direct oxygen supply to the hypoxic areas. Klin Monatsbl Augenheilkd 186:485–487PubMedCrossRefGoogle Scholar
  40. Rattenholl A, Steinhoff M (2008) Proteinase-activated receptor-2 in the skin: receptor expression, activation and function during health and disease. Drug News Perspect 21:369–381PubMedCrossRefGoogle Scholar
  41. Rohatgi T, Sedehizade F, Sabel B, Reiser G (2003) Protease–activated receptor subtype expression in developing eye and adult retina of the rat after optic nerve crush. J Neurosci Res 73:246–254PubMedCrossRefGoogle Scholar
  42. Saccà S, Izzotti A (2008) Oxidative stress and glaucoma: injury in the anterior segment of the eye. Prog Brain Res 173:385–407PubMedCrossRefGoogle Scholar
  43. Scarborough RM (2003) Protease-activated receptor-2 antagonists and agonists. Curr Med Chem-Cardiovasc Hematol Agents 1:73–82PubMedCrossRefGoogle Scholar
  44. Shpacovitch VM, Seeliger S, Huber-Lang M et al (2007) Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils. Exp Dermatol 16:799–806PubMedCrossRefGoogle Scholar
  45. Steinberg SF (2005) The cardiovascular actions of protease-activated receptors. Mol Pharmacol 67:2PubMedCrossRefGoogle Scholar
  46. Steinhoff M, Neisius U, Ikoma A et al (2003) Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 23:6176–6180PubMedGoogle Scholar
  47. Striggow F, Riek-Burchardt M, Kiesel A et al (2001) Four different types of protease–activated receptors are widely expressed in the brain and are up–regulated in hippocampus by severe ischemia. Eur J Neurosci 14:595–608PubMedCrossRefGoogle Scholar
  48. Van Bergen NJ, Wood JPM, Chidlow G et al (2009) Recharacterization of the RGC-5 retinal ganglion cell line. Investig Ophthalmol Vis Sci 50:4267–4272CrossRefGoogle Scholar
  49. Vesey DA, Kruger WA, Poronnik P, Gobé GC, Johnson DW (2007) Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation. Am J Physiol-Ren Physiol 293:F1441–F1449CrossRefGoogle Scholar
  50. Wang Y, Luo W, Reiser G (2007) Activation of protease-activated receptors in astrocytes evokes a novel neuroprotective pathway through release of chemokines of the growth-regulated oncogene/cytokine-induced neutrophil chemoattractant family. Eur J Neurosci 26:3159–3168PubMedCrossRefGoogle Scholar
  51. Xiao-Ming Y (2000) Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res 10:161–167CrossRefGoogle Scholar
  52. Zhang H, Yang X, Yang H et al (2007) Modulation of mast cell proteinase-activated receptor expression and IL-4 release by IL-12. Immunol Cell Biol 85:558–566PubMedCrossRefGoogle Scholar
  53. Zhou (2011) Activation of PAR2 or/and TLR4 promotes SW620 cell proliferation and migration via phosphorylation of ERK1/2. Oncol Rep 25:503–511PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Southwest Hospital, Southwest Eye HospitalThird Military Medical UniversityChongqingChina
  2. 2.Key Lab of Visual Damage and Regeneration & Restoration of ChongqingChongqingChina
  3. 3.The second affiliated Hospital of Chongqing Medical UniversityChongqingChina
  4. 4.State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Burns, Southwest Hospital, Third Military Medical UniversityChongqingChina

Personalised recommendations